epigallocatechin gallate has been researched along with Benign Psychomotor Epilepsy, Childhood in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auladell, C; Barenys, M; Calpena, AC; Camins, A; Cano, A; Espina, M; Ettcheto, M; Folch, J; García, ML; Sánchez-López, E | 1 |
| Alexiou, C; Cicha, I; Friedrich, RP; Janko, C; Pöttler, M; Unterweger, H | 1 |
| Cui, Z; Jia, L; Qu, Z; Si, P; Sun, C; Wang, W; Xie, T; Xue, Y; Zhen, J | 1 |
3 other study(ies) available for epigallocatechin gallate and Benign Psychomotor Epilepsy, Childhood
| Article | Year |
|---|---|
Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsy.
Topics: Animals; Catechin; Drug Carriers; Emulsions; Epilepsy, Temporal Lobe; Mice; Mice, Inbred C57BL; Nanoparticles; Particle Size; PC12 Cells; Polyethylene Glycols; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Seizures | 2018 |
Nanomedicine for neuroprotection.
Topics: Animals; Catechin; Epilepsy, Temporal Lobe; Humans; Nanomedicine; Nanoparticles; Neuroprotection; Neuroprotective Agents; Reperfusion Injury; Sphingomyelin Phosphodiesterase | 2019 |
(-)-Epigallocatechin-3-Gallate Protects Against Lithium-Pilocarpine-Induced Epilepsy by Inhibiting the Toll-Like Receptor 4 (TLR4)/Nuclear Factor-κB (NF-κB) Signaling Pathway.
Topics: Animals; Catechin; Disease Models, Animal; Epilepsy; Epilepsy, Temporal Lobe; Hippocampus; Lithium; Long-Term Potentiation; Male; Neurons; Neuroprotective Agents; NF-kappa B; Pilocarpine; Rats; Rats, Sprague-Dawley; Seizures; Signal Transduction; Toll-Like Receptor 4 | 2019 |